These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24400802)

  • 21. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies.
    Fusaro M; Crepaldi G; Maggi S; D'Angelo A; Calo L; Miozzo D; Fornasieri A; Gallieni M
    Curr Vasc Pharmacol; 2011 Nov; 9(6):763-9. PubMed ID: 21623708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New anticoagulants for the prevention of stroke in atrial fibrillation.
    Höchtl T; Huber K
    Fundam Clin Pharmacol; 2012 Feb; 26(1):47-53. PubMed ID: 21883447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulant and antiplatelet therapy in patients with chronic kidney disease: risks versus benefits review.
    Harmon JP; Zimmerman DL; Zimmerman DL
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):624-8. PubMed ID: 24100216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients.
    Krüger T; Brandenburg V; Schlieper G; Marx N; Floege J
    Nephrol Dial Transplant; 2013 Mar; 28(3):534-41. PubMed ID: 23180880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Escobar C; Barrios V; Jimenez D
    Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke and bleeding in atrial fibrillation with chronic kidney disease.
    Olesen JB; Lip GY; Kamper AL; Hommel K; Køber L; Lane DA; Lindhardsen J; Gislason GH; Torp-Pedersen C
    N Engl J Med; 2012 Aug; 367(7):625-35. PubMed ID: 22894575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D; Antonucci E; Zanazzi M; Grifoni E; Testa S; Ageno W; Palareti G
    Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding events associated with novel anticoagulants: a case series.
    Mirzaee S; Tran TT; Amerena J
    Heart Lung Circ; 2013 Dec; 22(12):1043-7. PubMed ID: 23721697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [What is the current use of vitamin K antagonists in the elderly?].
    Vidal JS; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):17-22. PubMed ID: 24463060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atrial fibrillation and anticoagulation in hemodialysis patients: A complex decision].
    Delanaye P; Bouquegneau A; Dubois BE; Sprynger M; Mariat C; Krzesinski JM; Lancellotti P
    Nephrol Ther; 2017 Apr; 13(2):59-66. PubMed ID: 28216253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
    ROCKET AF Study Investigators
    Am Heart J; 2010 Mar; 159(3):340-347.e1. PubMed ID: 20211293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New oral anticoagulants in elderly patients with atrial fibrillation.
    Deedwania PC
    Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke prevention in atrial fibrillation: do we still need warfarin?
    Diener HC; Weber R; Lip GY; Hohnloser SH
    Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.